Dominari Holdings Inc. (NASDAQ:DOMH – Get Free Report) was the target of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 15,600 shares, a growth of 578.3% from the March 31st total of 2,300 shares. Currently, 0.3% of the company’s shares are sold short. Based on an average daily volume of 12,300 shares, the days-to-cover ratio is currently 1.3 days.
Dominari Trading Up 2.2 %
Shares of DOMH traded up $0.06 during mid-day trading on Friday, reaching $2.76. 5,293 shares of the stock traded hands, compared to its average volume of 11,976. The stock has a fifty day simple moving average of $2.39 and a 200 day simple moving average of $2.26. Dominari has a 12-month low of $1.76 and a 12-month high of $3.67.
Dominari (NASDAQ:DOMH – Get Free Report) last released its quarterly earnings results on Monday, April 1st. The company reported ($1.28) earnings per share for the quarter. The company had revenue of $1.01 million for the quarter.
Insider Transactions at Dominari
About Dominari
Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Further Reading
- Five stocks we like better than Dominari
- Where to Find Earnings Call Transcripts
- 3 Stocks Leading the U.S. Agriculture Comeback
- Energy and Oil Stocks Explained
- How to Use Put Debit Spreads to Profit From Falling Stocks
- How to Invest in Insurance Companies: A GuideĀ
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Dominari Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dominari and related companies with MarketBeat.com's FREE daily email newsletter.